CYTOKINETICS, INCORPORATED Retained Earnings
CYTOKINETICS, INCORPORATED (CYTK) had Retained Earnings of -$3.89 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$3.89B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$3.69B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$3.49B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$3.30B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$3.89B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$3.69B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | -$3.49B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$3.30B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | -$3.00B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$2.86B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | -$2.70B 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$2.55B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$2.39B 10-Q · filed 2024-08-09 | |
| 2024-03-31 | -$2.25B 10-Q · filed 2024-05-10 | |
| 2023-12-31 | -$2.11B 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$1.98B 10-Q · filed 2023-11-03 | |
| 2023-06-30 | -$1.85B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | -$1.72B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | -$1.59B 10-K · filed 2024-02-28 | |
| 2022-09-30 | -$1.45B 10-Q · filed 2022-11-04 | |
| 2022-06-30 | -$1.31B 10-Q · filed 2022-08-05 | |
| 2022-03-31 | -$1.29B 10-Q · filed 2022-05-06 | |
| 2022-01-01 | -$1.20B 10-K · filed 2023-03-01 | |
| 2021-12-31 | -$1.21B 10-K · filed 2023-03-01 | |
| 2021-09-30 | -$1.18B 10-Q · filed 2021-11-05 | |
| 2021-06-30 | -$1.10B 10-Q · filed 2021-08-06 | |
| 2021-03-31 | -$1.04B 10-Q · filed 2021-05-07 | |
| 2020-12-31 | -$992.31M 10-K · filed 2022-02-25 | |
| 2020-09-30 | -$948.38M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -$945.20M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | -$904.42M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | -$865.02M 10-K · filed 2021-02-26 | |
| 2019-09-30 | -$834.38M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | -$804.80M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$772.69M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$743.32M 10-K · filed 2020-03-04 | |
| 2018-09-30 | -$714.40M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$688.22M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | -$658.35M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$646.08M 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$605.60M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | -$573.24M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | -$544.16M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$518.29M 10-K · filed 2018-03-05 | |
| 2016-09-30 | -$525.45M 10-Q/A · filed 2016-12-15 | -$526.92M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$558.81M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$547.20M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | -$534.74M 10-K · filed 2017-03-06 | |
| 2015-09-30 | -$525.51M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$516.67M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | -$506.12M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | -$497.24M 10-K · filed 2016-03-03 | |
| 2014-09-30 | -$505.69M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | -$499.71M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$491.34M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | -$482.60M 10-K · filed 2015-03-06 | |
| 2013-09-30 | -$489.13M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | -$476.54M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | -$461.50M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | -$448.88M 10-K · filed 2014-03-07 | |
| 2012-09-30 | -$437.42M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | -$427.38M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | -$418.44M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | -$408.51M 10-K · filed 2013-03-15 | |
| 2011-09-30 | -$396.63M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | -$385.99M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | -$360.65M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |